caret icon Back to all discussions

Feeling your feelings about regulatory decisions

After yesterday's announcement by CMS regarding coverage of an Alzheimer's therapy (link to the article below), there's likely to be a lot of feelings. For me, I'm frustrated that we're ONLY at this point, with so few therapies available to treat the disease.

Let's chat about it.

https://www.nytimes.com/2022/01/11/health/aduhelm-medicare-alzheimers.html?campaign_id=60&emc=edit_na_20220111&instance_id=0&nl=breaking-news&ref=cta&regi_id=62186417&segment_id=79377&user_id=4c4636ee37676ef5a6c604df8a045d74

    or create an account to reply.